Fortis Healthcare (196.6)
Investors with a short-term horizon can consider selling the stock of Fortis Healthcare at current levels. The stock plunged 4.5 per cent on Thursday breaking below a significant long-term support...18-05-2017
Fortis Healthcare (196.6)
Investors with a short-term horizon can consider selling the stock of Fortis Healthcare at current levels. The stock plunged 4.5 per cent on Thursday breaking below a significant long-term support...Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdSingh brothers said to seek Rs250/share to sell off Fortis Healthcare
TPG Capital, General Atlantic and IHH Health, Parkway Pantai are in discussions with Singh brothers to buy controlling stake in Fortis Healthcare for Rs250/share and SRL Diagnostics for Rs2,000 croreOpening bell: US markets close little changed; HDFC, Fortis, banking stocks in focus
In other news, the cabinet also cleared national steel policy that favours domestic manufacturers in government projectsDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereFortis gets notice from Maharashtra FDA for two hospitals
Matter pertains to single-use devices that are used for angioplasty to remove blockages in arteriesIntimation Of Proceedings And Results Of Tribunal Convened Meetings Under The SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015 ('Listing Regulations')
The Equity Shareholders' Meeting was convened on April 27, 2017, as per the order of the Chandigarh Bench of the National Company Law Tribunal dated February 21, 2017, for approving the proposed Scheme ('Order'). Separately, the unsecured creditors of the Company approved the Scheme in the meeting of unsecured creditors convened on April 26, 2017, as per the Order. The voting results of the same are enclosed.